Q4 2020 Vascular Biogenics Ltd Earnings Call Transcript
Greetings. Welcome to the VBL Therapeutics Fourth Quarter and Full Year 2020 Earnings Call. (Operator Instructions) Please note, this conference is being recorded.
I will now turn the conference over to the VBL team. You may begin.
Thank you, Shamali. Good morning, everyone. And once again, thank you for joining us for today's VBL Therapeutics Fourth Quarter and Full Year 2020 Financial Results and Corporate Update Conference Call. Leading the call this morning will be Professor Dror Harats, Chief Executive Officer; and Amos Ron, Chief Financial Officer. A press release with the company's financial results for the full year 2020 was issued earlier this morning and is available on the Investor Relations page of our website at vblrx.com.
Before I turn the call over to management, I'd like to remind everyone that during this call, forward-looking statements made by management are intended to fall within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934 as
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |